128 related articles for article (PubMed ID: 22108477)
1. Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy.
Luzzi R; Feragalli B; Belcaro G; Cesarone MR; Cornelli U; Dugall M; Hosoi M
Panminerva Med; 2011 Sep; 53(3 Suppl 1):51-5. PubMed ID: 22108477
[TBL] [Abstract][Full Text] [Related]
2. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
[TBL] [Abstract][Full Text] [Related]
3. Microcirculatory efficacy of topical treatment with aescin + essential phospholipids gel on transcutaneous PO2 in venous insufficiency.
Cesarone MR; Belcaro G; Ippolito E; Ricci A; Ruffini M; Dugall M
Angiology; 2004; 55 Suppl 1():S7-10. PubMed ID: 15156250
[TBL] [Abstract][Full Text] [Related]
4. Microcirculatory efficacy of topical treatment with aescin + essential phospholipids gel in venous insufficiency and hypertension: new clinical observations.
Belcaro G; Cesarone MR; Dugall M
Angiology; 2004; 55 Suppl 1():S1-5. PubMed ID: 15156249
[TBL] [Abstract][Full Text] [Related]
5. Microcirculatory effects of Viatromb spray gel heparin in chronic venous insufficiency: evaluation of TcPO2 and PCO2--a product evaluation study.
Rosaria Cesarone M; Belcaro G; Errichi S; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
Angiology; 2007; 58 Suppl 1():21S-26S. PubMed ID: 17478879
[TBL] [Abstract][Full Text] [Related]
6. Improvement of microcirculation and healing of venous hypertension and ulcers with Crystacide: evaluation with a microcirculatory model, including free radicals, laser doppler flux, and PO2/PCO2 measurements.
Belcaro G; Cesarone MR; Errichi BM; Di Renzo A; Errichi S; Ricci A; Gizzi G; Dugall M; Cacchio M; Ruffini I; Fano F; Vinciguerra G; Grossi MG
Angiology; 2007; 58(3):323-8. PubMed ID: 17626987
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical treatment with aescin + essential phospholipids gel in venous insufficiency and hypertension.
Ruffini I; Belcaro G; Cesarone MR; Dugall M
Angiology; 2004; 55 Suppl 1():S19-21. PubMed ID: 15156253
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical treatment with aescin + essential phospholipids gel in a microcirculatory model of venous insufficiency.
Belcaro G; Cesarone MR; Dugall M
Angiology; 2004; 55 Suppl 1():S15-8. PubMed ID: 15156252
[TBL] [Abstract][Full Text] [Related]
9. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
[TBL] [Abstract][Full Text] [Related]
10. Variations in plasma free radicals with topical aescin + essential phospholipids gel in venous hypertension: new clinical data.
Ricci A; Ruffini I; Cesarone MR; Cornelli U; Corsi M; Belcaro G; Ippolito E; Dugall M
Angiology; 2004; 55 Suppl 1():S11-4. PubMed ID: 15156251
[TBL] [Abstract][Full Text] [Related]
11. Microvascular alterations in diabetic microangiopathy: topical treatment with Essaven gel--a placebo-controlled, randomized study.
Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Griffin M
Angiology; 2001 Dec; 52 Suppl 3():S35-41. PubMed ID: 11775647
[TBL] [Abstract][Full Text] [Related]
12. LINFAVENIX: improvement of signs and symptoms of chronic venous insufficiency and microangiopathy.
Cesarone MR; Belcaro G; Grossi MG; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Cacchio M
Minerva Cardioangiol; 2008 Oct; 56(5 Suppl):55-61. PubMed ID: 19597413
[TBL] [Abstract][Full Text] [Related]
13. Microangiopathy and venous ulceration: topical treatment with Essaven gel--a placebo-controlled, randomized study.
Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Griffin M
Angiology; 2001 Dec; 52 Suppl 3():S17-21. PubMed ID: 11775644
[TBL] [Abstract][Full Text] [Related]
14. Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy--a placebo-controlled, randomized study.
Cesarone MR; Incandela L; Belcaro G; De Sanctis MT; Ricci A; Griffin M
Angiology; 2001 Dec; 52 Suppl 3():S43-8. PubMed ID: 11775648
[TBL] [Abstract][Full Text] [Related]
15. Aescin-based topical formulation to prevent foot wounds and ulcerations in diabetic microangiopathy.
Hu S; Belcaro G; Dugall M; Hosoi M; Togni S; Maramaldi G; Giacomelli L
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4337-4342. PubMed ID: 27831638
[TBL] [Abstract][Full Text] [Related]
16. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study.
Appendino G; Belcaro G; Cornelli U; Luzzi R; Togni S; Dugall M; Cesarone MR; Feragalli B; Ippolito E; Errichi BM; Pellegrini L; Ledda A; Ricci A; Bavera P; Hosoi M; Stuard S; Corsi M; Errichi S; Gizzi G
Panminerva Med; 2011 Sep; 53(3 Suppl 1):43-9. PubMed ID: 22108476
[TBL] [Abstract][Full Text] [Related]
17. Topical treatment of venous microangiopathy in patients with venous ulceration with Essaven gel--a placebo-controlled, randomized study.
De Sanctis MT; Incandela L; Belcaro G; Cesarone MR
Angiology; 2001 Dec; 52 Suppl 3():S29-34. PubMed ID: 11775646
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of topical treatment with aescin + essential phospholipids gel on capillary fragility.
Cesarone MR; Ricci A; Di Renzo A; Belcaro G; Dugall M
Angiology; 2004; 55 Suppl 1():S23-5. PubMed ID: 15156254
[TBL] [Abstract][Full Text] [Related]
19. Microcirculatory dysfunction in chronic venous insufficiency (CVI).
Jünger M; Steins A; Hahn M; Häfner HM
Microcirculation; 2000; 7(6 Pt 2):S3-12. PubMed ID: 11151969
[TBL] [Abstract][Full Text] [Related]
20. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]